
Adjunct Professor of Biomedical Engineering
Ravi Bellamkonda is the Vinik Dean of the Pratt School of Engineering at Duke University. Prior to becoming dean, Bellamkonda served as the Wallace H. Coulter Professor and chair of the Department of Biomedical Engineering at Georgia Institute of Technology and Emory University. He is committed to fostering transformative research and pedagogical innovation as well as programs that create an entrepreneurial mindset amongst faculty and students.
A trained bioengineer and neuroscientist, Bellamkonda holds an undergraduate degree in biomedical engineering. His graduate training at Brown University was in biomaterials and medical science (with Patrick Aebischer), and his post-doctoral training at Massachusetts Institute of Technology focused on the molecular mechanisms of axon guidance and neural development (with Jerry Schneider and Sonal Jhaveri). His current research explores the interplay of biomaterials and the nervous system for neural interfaces, nerve repair and brain tumor therapy.
From 2014 to 2016, Bellamkonda served as president of the American Institute for Biological and Medical Engineering (AIMBE), the leading policy and advocacy organization for biomedical engineers with representation from industry, academia and government. Bellamkonda’s numerous awards include the Clemson Award for Applied Research from the Society for Biomaterials, EUREKA award from National Cancer Institute (National Institutes of Health), CAREER award from the National Science Foundation and Best Professor Award from the Georgia Tech Biomedical Engineering student body.
A trained bioengineer and neuroscientist, Bellamkonda holds an undergraduate degree in biomedical engineering. His graduate training at Brown University was in biomaterials and medical science (with Patrick Aebischer), and his post-doctoral training at Massachusetts Institute of Technology focused on the molecular mechanisms of axon guidance and neural development (with Jerry Schneider and Sonal Jhaveri). His current research explores the interplay of biomaterials and the nervous system for neural interfaces, nerve repair and brain tumor therapy.
From 2014 to 2016, Bellamkonda served as president of the American Institute for Biological and Medical Engineering (AIMBE), the leading policy and advocacy organization for biomedical engineers with representation from industry, academia and government. Bellamkonda’s numerous awards include the Clemson Award for Applied Research from the Society for Biomaterials, EUREKA award from National Cancer Institute (National Institutes of Health), CAREER award from the National Science Foundation and Best Professor Award from the Georgia Tech Biomedical Engineering student body.
Appointments and Affiliations
- Adjunct Professor of Biomedical Engineering
Contact Information
- Email Address: ravi@duke.edu
- Websites:
Education
- Ph.D. Brown University, 1994
Research Interests
Engineered devices for brain tumor therapy; immunomodulation for peripheral and central nervous system repair; biomaterials; brain-machine interfaces.Courses Taught
- EGR 393: Research Projects in Engineering
In the News
- Engineering Dean Bellamkonda Named Provost at Emory University; Glass to Serve …
- Duke Launches Center to Bring Computational Thinking to All Students (Oct 12, 2…
- Seven From Duke Named Fellows of American Association for the Advancement of Sc…
- An Immigrant's Story: How Three Decades in the U.S. Shaped Ravi Bellamkonda (Au…
- Brain Tumor 'Pied Piper' Device Earns Breakthrough Status (Feb 6, 2019 | Pratt …
- Duke Launches Marcus Center for Cellular Cures to Tackle Autism, MS, Stroke (Ma…
- The Workplace of the Future (Aug 30, 2017)
- Duke Engineering Dean Discusses Confronting and Overcoming Biases (Mar 21, 2017)
- Engineering Dean on Immigration Policy and Attracting the Best Minds (Mar 20, 2…
- Tumor-Seeking Salmonella Treats Brain Tumors (Jan 11, 2017)
Representative Publications
- Swan, Sheridan L., Nalini Mehta, Ekaterina Ilich, Steven H. Shen, Daniel S. Wilkinson, Alexa R. Anderson, Tatiana Segura, Luis Sanchez-Perez, John H. Sampson, and Ravi V. Bellamkonda. “IL7 and IL7 Flt3L co-expressing CAR T cells improve therapeutic efficacy in mouse EGFRvIII heterogeneous glioblastoma.” Frontiers in Immunology 14 (January 2023): 1085547. https://doi.org/10.3389/fimmu.2023.1085547.
- Enam, Syed Faaiz, Cem Y. Kilic, Jianxi Huang, Brian J. Kang, Reed Chen, Connor S. Tribble, Ekaterina Ilich, et al. “Cytostatic hypothermia and its impact on glioblastoma and survival.” Sci Adv 8, no. 47 (November 25, 2022): eabq4882. https://doi.org/10.1126/sciadv.abq4882.
- Motz, Cara T., Victoria Kabat, Tarun Saxena, Ravi V. Bellamkonda, and Cheng Zhu. “Neuromechanobiology: An Expanding Field Driven by the Force of Greater Focus.” Advanced Healthcare Materials 10, no. 19 (October 2021): e2100102. https://doi.org/10.1002/adhm.202100102.
- Park, Eunyoung, Johnathan G. Lyon, Melissa Alvarado-Velez, Martha I. Betancur, Nassir Mokarram, Jennifer H. Shin, and Ravi V. Bellamkonda. “Enriching neural stem cell and anti-inflammatory glial phenotypes with electrical stimulation after traumatic brain injury in male rats.” Journal of Neuroscience Research 99, no. 7 (July 2021): 1864–84. https://doi.org/10.1002/jnr.24834.
- Yeon, P., S. K. Rajan, J. Falcone, J. L. Gonzalez, G. S. May, R. V. Bellamkonda, O. Brand, M. S. Bakir, and M. Ghovanloo. “Microfabrication, coil characterization, and hermetic packaging of millimeter-sized free-floating neural probes.” Ieee Sensors Journal 21, no. 12 (June 15, 2021): 13837–48. https://doi.org/10.1109/JSEN.2021.3068077.